The Journal of Organic Chemistry
Article
2H), 4.74 (mc, 2H), 6.82−6.94 (m, 2H), 7.07−7.62 (m, 8 H) 7.94
(mc, 1H), 8.47 (mc, 1H); 13C NMR (CDCl3, 100 MHz) δ = 50.1, 59.1,
66.3, 122.3, 127.0, 128.4, 129.7, 136.2, 136.8, 137.2, 141.8, 145.7,
146.5, 149.3, 149.8, 156.8, 157.3; MS (CI, NH3) m/z = 319.2 (100)
[(M + 1)+], HRMS (CI, NH3) m/z [(M + 1)+] calcd for C19H18N4O
319.15589, found 319.15660.
steps) after purification via column chromatography (aluminum oxide,
EE → EE/EtOH 98:2).
N-(2-Dimethylaminoethyl)-N-(1-methyl-1H-imidazol-4-ylmethyl)-
1
benzamide (23): H NMR (CDCl3, 300 MHz) δ = 1.90−2.29 (m,
6H), 2.29−2.56 (m, 2H), 3.26−3.57 (m, 2H), 3.58 (s, 3H), 4.31−4.62
(m, 2H), 6.59−6.94 (m, 1H), 7.2−7.38 (m, 5H), 7.38−7.51 (m, 1H);
13C NMR (CDCl3, 100 MHz) δ = 42.6, 45.6, 46.9, 47.7, 56.6, 57.6,
Methyl 6-((N-((Pyridine-2-yl)methyl)benzamido)methyl)pyridine-
3-carboxylate (21). Benzamide 21 was prepared via a multistep
reaction beginning with the oxidation of 6-methyl-nicotinic acid
leading to carbaldehyde 21a. Carbaldehyde 21a was obtained as a pale
yellow solid (1.54 g, 9.28 mmol, 62%) after purification via column
chromatography (silica gel, CH/EE 3:1).
117.9, 119.0, 126.6, 126.9, 128.3, 129.3, 136.8, 137.8, 138.8, 171.8; MS
(pos ESI) m/z = 287.3 (100) [(M + 1)+]; HRMS (APCI, MeOH/
NH4) m/z [(M + 1)+] calcd for C16H22N4O 287.18730, found
287.18719.
N-(2-Dimethylaminoethyl)-N-quinolin-2-ylmethylbenzamide
(24). Benzamide 24 was prepared via a reductive amination step
according to general procedure a followed by an acylation according to
general procedure b. Benzamide 24 was then obtained as a brown gum
(0.16 g, 0.48 mmol, 20% over two steps) after purification via column
chromatography (silica gel, DCM/MeOH 98:2 → DCM/MeOH
85:15).
Methyl 6-formylpyridin-3-carboxylate (21a):29 mp 107 °C; 1H
NMR (CDCl3, 400 MHz) δ = 4.00 (s, 3H), 8.03 (dd, 1H, J = 8.1 Hz, J
= 0.9 Hz), 8.46 (ddd, 1H, J = 8.1 Hz, J = 2.0 Hz, J = 0.9 Hz), 9.36 (dd,
1H, J = 2.0 Hz, J = 0.9 Hz), 10.14 (d, 1H, J = 0.9 Hz); 13C NMR
(CDCl3, 100 MHz) δ = 52.9, 121.2, 129.3, 138.4, 151.3, 155.0, 164.9,
192.7; MS (CI, NH3) m/z = 166.0 (100) [(M + 1)+].
N-(2-Dimethylaminoethyl)-N-quinolin-2-ylmethylbenzamide (24):
A reductive amination step according to the general procedure a
using 21a as carbonyl compound and 2-picolylamine as amine lead to
the secondary amine 21b which was obtained as dark brown oil (0.41
g, 1.59 mmol, 93%) without further purification.
1H NMR (CDCl3, 300 MHz) δ = 2.71−2.86 (m, 2H), 3.41 (s, 6H),
3.97−4.15 (m, 1H), 4.88−5.06 (m, 2H) 7.12−7.31 (m, 3H), 7.23−
7.57 (m, 4H), 7.68−7.74 (m, 1H), 7.76−7.82 (m, 1H), 8.01−8.10 (m,
2H); 13C NMR (CDCl3, 100 MHz) δ = 29.1, 40.9, 43.5, 53.6, 55.1,
62.7, 120.1, 126.6, 126.7, 126.8, 127.3, 127.6, 127.7, 128.3, 128.9,
129.8, 130.0, 135.3, 137.1, 147.6, 156.0, 173.4; MS (CI, NH3) m/z =
334.2 (100) [(M + 1)+]; HRMS (CI, NH3) m/z [(M + 1)+] calcd for
C21H23N3O 334.19194, found 334.19250.
Methyl 6-(((pyridine-2-yl)methylamino)methyl)pyridine-3-carbox-
1
ylate (21b): H NMR (CDCl3, 400 MHz) δ = 3.94 (s, 3H), 4.01 (s,
2H), 4.07 (s, 2H), 7.17 (ddd, 1H, J = 7.5 Hz, J = 4.9 Hz, J = 1.2 Hz),
7.33 (d, 1H, J = 7.9 Hz), 7.47 (dd, 1H, J = 8.2 Hz, J = 0.8 Hz), 7.64
(ddd, 1H, J = 7.7 Hz, J = 7.7 Hz, J = 1.9 Hz), 8.24 (dd, 1H, J = 8.1 Hz,
J = 2.2 Hz), 8.56 (ddd, 1H, J = 4.8 Hz, J = 1.7 Hz, J = 0.8 Hz), 9.15
(dd, 1H, J = 2.2 Hz, J = 0.8 Hz); 13C NMR (CDCl3, 100 MHz) δ =
52.4, 54.5, 54.6, 121.8, 122.3, 122.5, 124.6, 136.6, 137.7, 149.5, 150.7,
159.0, 164.0, 165.9 ppm.
The secondary amine 21b was the acylated according to the general
procedure c, and 21 was obtained as a pale yellow gum (0.33 g, 0.91
mmol, 58%) after purification via column chromatography (silica gel,
DCM/MeOH 97:3).
N-(2-Dimethylaminophenyl)-N-pyridin-2-ylmethylbenzamide
(25). The precursor amine was synthesized by the general procedure a
described above. A yellow liquid (0.58 g, 2.6 mmol, 71%) with the
following analytical data was obtained after column chromatography
(silica gel, CH/EE 5:1 → CH/EE 2:1).
1
N,N-Dimethyl-N-pyridin-2-ylmethylbenzene-1,2-diamine (25a): H
NMR (CDCl3, 300 MHz) δ = 2.70 (s, 6H), 4.50 (s, 2H), 6.52 (dd, 1H,
J = 8.0 Hz, J = 1.4 Hz), 6.68 (ddd, 1H, J = 7.6 Hz, J = 7.6 Hz, J = 1.4
Hz), 6.93 (dddd, 1H, J = 7.4 Hz, J = 7.4 Hz, J = 1.5 Hz, J = 0.5 Hz),
7.05 (dd, 1H, J = 7.7 Hz, J = 1.5 Hz), 7.14 (m, 1H), 7.34 (m, 1H), 7.61
(ddd, 1H, J = 7.6 Hz, J = 7.6 Hz, J = 1.8 Hz), 8.58 (mc, 1H); 13C NMR
(CDCl3, 100 MHz) δ = 44.2, 50.0, 110.6, 117.0, 119.2, 121.2, 122.1,
124.8, 136.8, 140.7, 142.9, 149.4, 159.8; MS (CI, NH3) m/z = 228.2
(100) [(M + 1)+]; HRMS (CI, NH3) m/z [(M + 1)+] calcd for
C14H17N3 228.15007, found 228.14970.
The secondary amine 25a was then acylated according to the
general procedure b, and 25 was isolated as a yellow gum (0.24 g, 0.7
mmol, 65%) after purification via column chromatography (silica gel,
DCM/MeOH 98:2 → 97:3).
N-(2-Dimethylaminophenyl)-N-pyridin-2-ylmethylbenzamide (25):
1H NMR (CDCl3, 300 MHz) δ = 2.52 (s, 6H), 4.26 (d, 1H, J = 15.2
Hz), 5.89 (d, 1H, J = 15.2 Hz), 6.78 (dd, 1H, J = 8.2 Hz, J = 1.4 Hz),
6.84 (dddd, 1H, J = 7.4 Hz, J = 7.4 Hz, J = 1.5 Hz, J = 0.3 Hz), 7.07
(dddd, 1H, J = 7.4 Hz, J = 7.4 Hz, J = 1.6 Hz, J = 0.7 Hz), 7.10−7.23
(m, 5H), 7.38−7.42 (m, 2H), 7.50−7.54 (m, 1H), 7.67 (ddd, 1H, J =
7.7 Hz, J = 7.7 Hz, J = 1.8 Hz), 8.58 (mc, 1H); 13C NMR (CDCl3, 100
MHz) δ = 42.8, 54.7, 120.1, 122.1, 122.4, 122.5, 127.1, 127.9, 128.3,
182.8, 129.5, 136.2, 136.8, 148.5, 149.2, 158.1, 171.2; MS (CI, NH3)
m/z = 332.2 (100) [(M + 1)+]; HRMS (CI, NH3) m/z [(M + 1)+]
calcd for C21H21N3O 332.17629, found 332.17640.
4-Oxo-4-phenyl-N,N-bis-pyridin-2-ylmethylbutyramide (26).
Amine 2 was acylated according to the general procedure b, and the
aliphatic amide 26 was obtained as a brown gum (0.52 g, 1.44 mmol,
82%) after purification with column chromatography (silica gel,
DCM/MeOH 98:2 → DCM/MeOH 90:10).
Methyl 6-((N-((pyridine-2-yl)methyl)benzamido)methyl)pyridine-
1
3-carboxylate (21): H NMR (CDCl3, 400 MHz) δ = 3.95 (s, 3H),
4.71 (br s, 1H), 4.80 (br s, 1H), 4.92 (br s, 2H), 7.13−7.59 (m, 8H),
7.70 (ddd, 1H, J = 6.5 Hz, J = 6.5 Hz, J = 3.3 Hz), 8.25 (mc, 1H), 8.54
(mc, 1H), 8.54 (d, 1H, J = 12.4 Hz), 9.13 (s, 1H); 13C NMR (CDCl3,
100 MHz) δ = 48.7, 50.5, 52.8, 53.0, 119.2, 119.7, 120.1, 120.7, 125.0,
125.2, 126.6, 128.0, 133.8, 134.9, 135.9, 148.0, 148.7, 149.1, 154.6,
159.3, 159.8; MS (CI, NH3) m/z = 362.1 (100) [(M + 1)+]; HRMS
(CI, NH3) m/z [(M + 1)+] calcd for C23H21N3O 362.15047, found
362.15040.
N,N-Bis(2-dimethylaminoethyl)benzamide (22). Compound 22a
was prepared according to a literature procedure30 followed by
distillation (bp16mbar = 90 °C) to obtain a colorless liquid (1.72 g, 10.8
mmol, 83%).
1
N,N,N′,N′-Tetramethyldiethylamine (22a): H NMR (CDCl3, 300
MHz) δ = 2.22 (s, 12H), 2.41 (t, 4H, J = 6.4 Hz), 2.71 (t, 4H, J = 6.4
Hz); 13C NMR (CDCl3, 100 MHz) δ = 45.7, 47.8, 59.4; MS (CI,
NH3) m/z = 160.2 (100) [(M + 1)+]; HRMS (CI, NH3) m/z [(M +
1)+] calcd for C8H21N3 160.18150, found 160.18137.
Benzamide 22 was prepared out of amine 22a according to the
general procedure b. Benzamide 22 was obtained as a yellow gum
(0.57 g, 2.2 mmol, 65%) after purification via bulb to bulb distillation
−2
(bp6.8*10
= 240 °C).
mbar
N,N-Bis(2-dimethylaminoethyl)benzamide (22): 1H NMR (CDCl3,
300 MHz) δ = 1.98−2.35 (m, 12H), 2.35−2.64 (m, 4H), 3.29−3.69
(m, 4H), 7.39 (m, 5H); 13C NMR (CDCl3, 100 MHz) δ = 45.7, 47.0,
55.5, 59.3, 122.0, 122.3, 136.5, 149.3, 159.9; MS (CI, NH3) m/z =
264.2 (100) [(M + 1)+]; HRMS (CI, NH3) m/z [(M + 1)+] calcd for
C15H25N3O 264.20810, found 264.20759.
4-Oxo-4-phenyl-N,N-bis-pyridin-2-ylmethyl-butyramide (26): 1H
NMR (CDCl3, 300 MHz) δ = 2.93 (t, 2H, J = 6.4 Hz), 3.41 (t, 2H,
J = 6.4 Hz), 4.78 (s, 2H), 4.82 (s, 2H), 7.14 (ddd, 1H, J = 7.6 Hz, J =
4.9 Hz, J = 1.2 Hz), 7.18 (ddd, 1H, J = 7.6 Hz, J = 4.9 Hz, J = 1.2 Hz),
7.31 (mc, 2H), 7.41−7.47 (m, 2H), 7.51−7.56 (m, 2H), 7.62 (td, 1H, J
= 7.7 Hz, J = 1.8 Hz), 7.69 (td, 1H, J = 7.7 Hz, J = 1.8 Hz), 7.98−8.02
(m, 2H), 8.48 (mc, 1H), 8.56 (mc, 1H); 13C NMR (CDCl3, 100 MHz)
δ = 27.6, 34.1, 51.9, 53.2, 120.9, 122.3, 122.4, 128.1, 128.7, 133.0,
N-(2-Dimethylamino-ethyl)-N-(1-methyl-1H-imidazol-4-
ylmethyl)benzamide (23). The secondary amine 23a was prepared
according to the general procedure a and than the secondary amine
23a was acylated according to the general procedure b. The benzamide
23 was obtained as a yellow gum (0.07 g, 0.2 mmol, 30% over two
K
dx.doi.org/10.1021/jo301349t | J. Org. Chem. XXXX, XXX, XXX−XXX